GVHD,Acute: Clinical Trials

5 trials for GVHD,Acute, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting, 1 terminated, 1 unknown. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 1, Recruiting 1, Terminated 1, Unknown 1, Withdrawn 1
Phase 21Terminated 1

Follow GVHD,Acute: new trials by email Literature Review of GVHD,Acute trials Research Report on GVHD,Acute

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)
TRX103 - Hematologic Malignancy, GvHD
Phase 1RecruitingTr1X, Inc.362024-04-082025-04-15
Safety and Efficacy Study of hAESCs Therapy for aGVHD
Human Amniotic Epithelial Stem Cell Injection - GVHD,Acute, aGVHD
Phase 1CompletedShanghai iCELL Biotechnology Co., Ltd, Shanghai, China102024-02-192026-10-15
Wharton Jelly Mesenchymal Stromal Cells as GVHD Prophylaxis
WJ-MSC infusion - Allogeneic Disease, GVHD,Acute
Phase 1UnknownCentral Hospital, Nancy, France122023-09-012023-05-11
Mesenchymal Stem Cells (MSCs) for Steroid Refractory Acute GVHD (SR-aGVHD)
OSSM-001 - GVHD,Acute
Phase 1WithdrawnOssium Health, Inc.2023-06-052022-12-23
A Study of IBI377 in Combination With Corticosteroids for the Treatment of First-Line Acute Graft-Versus-Host Disease
Itacitinib, Prednisone, Methylprednisolone - GVHD,Acute
Phase 1 / Phase 2TerminatedInnovent Biologics (Suzhou) Co. Ltd.12020-06-182020-10-29

Narrower conditions

Bronchiolitis Obliterans Syndrome (1)  ·  Graft vs Host Disease (1)  ·  Hematologic Neoplasms (1)  ·  Leukemia, Myelomonocytic, Chronic (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)

Broader conditions

Bone Marrow Diseases (1)  ·  Bronchial Diseases (1)  ·  Bronchiolitis (1)  ·  Bronchiolitis Obliterans (1)  ·  Bronchitis (1)  ·  Chronic Disease (1)  ·  Disease Attributes (1)  ·  Hematologic Diseases (1)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Leukemia (1)  ·  Leukemia, Lymphoid (1)  ·  Leukemia, Myeloid (1)  ·  Lung Diseases (1)

Interventions

Methylprednisolone (1)  ·  Prednisone (1)  ·  itacitinib (1)

Sponsors

Central Hospital, Nancy, France (1)  ·  Innovent Biologics (Suzhou) Co. Ltd. (1)  ·  Ossium Health, Inc. (1)  ·  Shanghai iCELL Biotechnology Co., Ltd, Shanghai, China (1)  ·  Tr1X, Inc. (1)

Countries

China (2)  ·  United States (1)

Top investigators

Maria Grazia Roncarolo, MD (1)  ·  Sagar Munjal (1)  ·  Xiaojun Huang, M.D., PhD (1)

Results publications

PMID 42495646

NIH funding

2023 (1)